Analysis of the expenses on pharmaceutical provision of newborns in Ukraine

Authors

DOI:

https://doi.org/10.24959/sphhcj.19.141

Keywords:

pharmaceutical provision, medicines, parapharmaceutical products, expenses, newborn babies

Abstract

Aim. To analyze the expenses on pharmaceutical provision of newborns in Ukraine.

Materials and Methods. Data from the State Register of Medicines of Ukraine, the electronic database of the Morion information retrieval program and the price lists of the weekly “Pharmacy” as of December 15, 2018; logical, system-analytical, mathematical-statistical and comparative methods of analysis were used.

Results. The analysis of the list of pharmaceutical provision for newborns has shown that it consists of approximately 80% of the parafarmaceutical products and 20% of medicines. A comparative analysis of the effectiveness and availability of pharmaceutical supply of newborns in Ukraine has demonstrated that the average total cost is about 12600 UAH per month, and the availability factor is 1.39.

Conclusions. The results of the analysis conducted can be used when forming the financial aid for newborns in Ukraine to improve the quality of pharmaceutical provision, expand the range of products needed, and increase their availability.

Author Biography

G. M. Iurchenko, National univercity of pharmacy

assistant professor of the department of organisation and economy of pharmacy

References

Health 2020: Fundamentals of the European Strategy to support the actions of the entire state and society in the interests of health and well–being. (2012). – Copenhagen: WHO WHO,.

Ustiuhova, A. M. (2009). Metodicheskie podkhody k sovershenstvovaniiu organizatsii lekarstvennogo obespecheniia novorozhdennykh detei v usloviiakh statcionara [Methodical approaches to improving the organization of drug provision of newborns in the hospital]. Extended abstract of candidate’s thesis. Moscow, 24.

Bazargani, Y. T., Ewen, M., Boer, A. de, Leufkens, H. G. M., Mantel–Teeuwisse, A. K. (2014). Essential Medicines Are More Available than Other Medicines around the Globe. PLoS ONE, 9 (2), e87576. doi: 10.1371/journal.pone.0087576.

Nemchenko, A. S., Kubarieva, I. V., Kosiachenko, K. L. (2009). Zaporozhskyi medytsynskyi zhurnal, 5, 122–125.

Wendykowska, K., Władysiuk, M., Bondaryk, K., Budasz–Świderska, M., Ofierska–Sujkowska, G., Łanda, K. (2013). Proceeding from Praktychni aspekty vprovadzhennia otsinky tekhnolohii okhorony zdorovia v Ukraini: materialy mizhnarodnoi naukovo–praktychoi konferentsii (5–6 bereznia 2013 r.) (pp. 70–82). Kyiv.

Belousov, Yu. B., Gratcianskaia, A. N. (2015). Farmateka, 1 (155), 15–18.

Vorobev, P. A. (2017). Farmatsevticheskii vestnik, 9 (456), 6.

Baranov, A. A., Gorelov, A. B., Zadorozhnaia, V. I. at al. (2017). Pediatricheskaia farmakologiia, 4 (1), 6–18.

Kukes, V. G., Volodin, H. H., Sychev, D. A., Koman, I. E. (2006). Vestnik pediatrii, farmakologii i nutritciologii, 3 (1), 16–23.

Kirsanov, D. (2016). Ezhenedelnik “Apteka”, 1023 (2). Available at: http://www.apteka.ua/article/358052.

Kirsanov, D. (2016). Ezhenedelnik “Apteka”, 1040 (19). Available at: http://www.apteka.ua/article/372763

State Statistics Service of Ukraine. Available at: http://www.ukrstat.gov.ua/

Published

2019-03-11

Issue

Section

Social medicine and pharmacy: past, present and development prospects